Cargando…
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery
MbtI from Mycobacterium tuberculosis (Mtb) is a Mg(2+)-dependent salicylate synthase, belonging to the chorismate-utilizing enzyme (CUE) family. As a fundamental player in iron acquisition, MbtI promotes the survival and pathogenicity of Mtb in the infected host. Hence, it has emerged in the last de...
Autores principales: | Mori, Matteo, Villa, Stefania, Chiarelli, Laurent R., Meneghetti, Fiorella, Bellinzoni, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675255/ https://www.ncbi.nlm.nih.gov/pubmed/38004425 http://dx.doi.org/10.3390/ph16111559 |
Ejemplares similares
-
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
por: Chiarelli, Laurent R., et al.
Publicado: (2019) -
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
por: Mori, Matteo, et al.
Publicado: (2021) -
Shedding X-ray Light on the Role of Magnesium
in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
por: Mori, Matteo, et al.
Publicado: (2020) -
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies
por: Pini, Elena, et al.
Publicado: (2018) -
Mycobacterium tuberculosis DosR is Required for Activity of the P(mbtB) and P(mbtI) Promoters under Hypoxia
por: Schreuder, Lise J., et al.
Publicado: (2014)